Document:

Schedule of Executive Officers Party to the 2007 Change in Control Agreement

 EXHIBIT 10.2 
 SCHEDULE OF EXECUTIVE OFFICERS PARTY TO THE 
 2007 CHANGE IN CONTROL AGREEMENT FILED AS EXHIBIT 10.1

 Each of the parties identified below is party to a change in control agreement (“2007 CIC Agreement”) with Advanced Medical Optics, Inc.
substantially in the form of Exhibit 10.1 to the Quarterly Report on Form 10-Q of Advanced Medical Optics, Inc. for the quarter ended June 29, 2007: 
  

					
	Name of Executive	 	 Benefit Level Under
 Section 6 of the
 2007 CIC
Agreement
	 	 Benefit Level Under
 Section 8 of the
 2007 CIC Agreement

	 Angelo Rago
	 	Two Times	 	Two TimesForm of Director Restricted Stock Unit Agreement

 EXHIBIT 10.3 
 [date] 
 [Name and Address of Director] 
  

	Re:	ADVANCED MEDICAL OPTICS, INC. NONEMPLOYEE DIRECTOR 

 RESTRICTED STOCK UNIT AGREEMENT 
 Dear _______________: 
 Pursuant to the terms of the Advanced Medical Optics, Inc. 2005 Incentive Compensation Plan [or 2004 Stock Incentive Plan] (the “Plan”), Advanced Medical Optics, Inc., a Delaware corporation (the
“Company”), hereby offers to grant to you the number of restricted stock units set forth in Section 2(a) below, on the terms and conditions and subject to the restrictions set forth in the Plan and this Agreement. 
 To accept this offer, you should complete and sign the enclosed copy of this Agreement, and return it to the Company. This Agreement contains important
information and you should read it carefully before you sign it. 
 1. Definitions. Capitalized terms used in this Agreement that are
not otherwise defined herein shall have the same meanings as in the Plan. 
 2. Basic Terms. 
 (a) The Restricted Stock Units. The Company hereby offers to grant to you an aggregate of __________ restricted stock units (the
“RSUs”) as an annual incentive award [pursuant to your election to defer your annual retainer pursuant to the Company’s Equity Exchange Program]. Except as otherwise provided by the Plan, each RSU granted hereunder shall represent the
right to receive one share of Common Stock upon the vesting of such RSU. 
 (b) Price. You are not required to pay any
purchase price for the RSUs. 

 3. Restrictions on the RSUs. Any RSUs received by you pursuant to this Agreement shall be subject
to the following restrictions: 
 (a) The RSUs may not be sold, assigned, transferred, pledged, hypothecated or otherwise
disposed of or encumbered until these restrictions lapse and are removed, and any additional requirements or restrictions contained in this Agreement or in the Plan have been satisfied, terminated or expressly waived by the Company in writing.

 (b) The restrictions imposed under Paragraph (a) above shall lapse and be removed (and all of the RSUs shall vest) as
of the day of the Company’s 2010 [2008 in the case of Equity Exchange Awards ]annual meeting of stockholders. 
 (c) If
your service as a director of the Company is terminated for any reason other than death or Total Disability, all of your rights to RSUs not vested at the time of termination shall immediately terminate. 
 (d) If you terminate your service as a director of the Company because of death or Total Disability, the restrictions imposed upon the
RSUs shall lapse and be removed (and all of the RSUs shall become fully vested) upon such termination of service. 
 (e) In
the event of a Change in Control, the restrictions imposed under Paragraph (a) above upon the RSUs shall lapse and be removed (and all of the RSUs shall become fully vested) as of the date of such Change in Control. 
 4. Voting and Other Rights. You shall have no rights of a stockholder of the Company until shares of Common Stock are issued upon vesting of your
RSUs. 
 5. Expiration of the Restricted Term. Upon the lapse and removal of the restrictions applicable to all or any portion of the
RSUs as provided in Section 3 above the Company intends to issue to you a Form 1099, and you shall be responsible for paying all taxes. If, however, the Company is required to withhold for taxes, you hereby agree, with respect to such RSUs, to
pay to the Company, in the form of cash or a certified or bank cashier’s check, an amount sufficient to satisfy any taxes or other amounts required by any governmental authority to be withheld and paid over to such authority for your account,
or to otherwise make arrangements satisfactory to the Board for the payment of such amounts. You hereby agree that if requested by the Board, you will make appropriate representations in a form satisfactory to the Board that such RSUs will not be
sold other than (i) pursuant to an effective registration statement under the Securities Act of 1933 or an applicable exemption from the registration requirements of such Act and (ii) in compliance with all applicable state securities laws
and regulations. 

 6. Agreement Subject to Plan. This Agreement is made pursuant to all of the provisions of the
Plan, which is incorporated herein by this reference, and is intended, and shall be interpreted in a manner, to comply therewith. Any provision hereof which is inconsistent with the Plan shall be superseded by and governed by this Agreement.

 7. No Rights to Continue as a Director. Nothing in the Plan or this Agreement shall confer upon you any right to continue as a
member of the Board of Directors of the Company or any subsidiary thereof or shall interfere with or restrict the right of the Company or its stockholders (or of a subsidiary or its stockholders, as the case may be) to terminate your service as a
director any time for any reason whatsoever, with or without cause. 
 8. Governing Law. This Agreement shall be governed by,
interpreted under, and construed and enforced in accordance with the internal laws, and not the laws pertaining to conflicts or choices of laws, of the State of California applicable to agreements made and to be performed wholly within the State of
California. 
 9. Agreement Binding on Successors. The terms of this Agreement shall be binding upon you and upon your heirs,
executors, administrators, personal representatives, transferees, assignees and successors in interest, and upon the Company and its successors and assignees. 
 10. No Assignment. Notwithstanding anything to the contrary in this Agreement, neither this Agreement nor any rights granted herein shall be assignable by you. 
 11. Necessary Acts. You hereby agree to perform all acts, and to execute and deliver any documents that may be reasonably necessary to carry out
the provisions of this Agreement, including but not limited to all acts and documents related to compliance with federal and/or state securities and/or tax laws. 
 12. Invalid Provisions. If any provision of this Agreement is found to be invalid or otherwise unenforceable under any applicable laws such invalidity or unenforceability shall not be construed as rendering any
other provisions contained herein invalid or unenforceable, and all such other provisions shall be given full force and effect to the same extent as though the invalid and unenforceable provision was not contained herein. 

 13. Notices. All notices or other communications required or permitted hereunder shall be in
writing, and shall be sufficient in all respects only if delivered in person or sent via certified mail, postage prepaid, or by expedited mail service such as Federal Express or DHL, or facsimile, addressed as follows: 
 If to you: 
  
  

			
	                   If to the
Company:
	    	 Advanced Medical Optics, Inc.
 Attn: General
Counsel
 1700 E. St. Andrew Place
 Santa Ana, CA 92705

Fax: (714) 247-8679

 14. Entire Agreement. This Agreement and the Plan contain the entire agreement and
understanding among the parties as to the subject matter hereof. 
 15. Headings. Headings are used solely for the convenience of the
parties and shall not be deemed to be a limitation upon or descriptive of the contents of any such Section. 
 16. Counterparts. This
Agreement may be executed in counterparts, each of which shall be deemed to be an original, and taken together shall constitute one and the same document. 
 17. Amendment. No amendment or modification hereof shall be valid unless it shall be in writing and signed by all parties hereto. 
 If you are in agreement with the foregoing, please fill in the information below, sign this Agreement, and return it to the Company to the attention of the General Counsel. 
  

			
	ADVANCED MEDICAL OPTICS, INC.
		
	By:	 	 
		 	James V. Mazzo, Chairman, President and Chief Executive Officer

 ACCEPTANCE 
 The undersigned hereby agrees to receive from ADVANCED MEDICAL OPTICS, INC. an aggregate of _________ Restricted Stock Units of the Company, and agrees to be bound by, and to comply with, the terms and provisions of
the Plan and the foregoing Restricted Stock Unit Agreement. 
 Dated: ________________, 2007. 
  

	
	 
	
	  
	(Please print your name exactly as you wish to hold title to the RSUs. If you want the transfer agent to use an address other than the one indicated on p. 4, provide that address to the
left.)Amended 2007 Performance Objectives

 EXHIBIT 10.4 
  

			
	AMO BONUS PLAN	 	

  

	
	
	 2007 PERFORMANCE OBJECTIVE
  
 (Amended Effective July 25, 2007)
  

  

 2007 PERFORMANCE OBJECTIVE 
 The funding for the 2007 Bonus Plan is weighted as follows: 
  

	o	75% based on achievement of the Adjusted Operating Income goal, and 

  

	o	25% based on achievement of the Revenue goal. 

 The goals will be for the
full year of AMO performance. 
 “Adjusted Operating Income” is defined as sales less cost of goods sold and all basic operating expenses of the
business. “Adjusted Operating Income” excludes the impact of charges or write-offs associated with acquisitions, recapitalizations, and unrealized gains or losses on derivative instruments. “Revenue” is defined as the total
dollar payment for goods and services that are credited to the income statement over the measurement period. Targets for both Adjusted Operating Income and Revenue include the impact of the May 2007 product recall. The target bonus funding level has
been reduced from 100% to 85% of previously set individual targets. 
 Each segment of the bonus is funded when AMO achieves the levels of Adjusted Operating
Income and Revenue performance, respectively, as indicated below. The plan will be funded at a minimum of 40%. 
  

 FUNDING TRIGGER ELEMENTS 
  

																	
	75% - ADJUSTED OPERATING INCOME	 	 	 	25% -
REVENUE
	 Performance
 Level
	 	2007 Adj Op
Range
Variance to
Target	 	Funding %
to Adj Op
Target	 	Plan
Funding	 	 	 	 Performance
 Level
	 	2007 Revenue
Range
Variance to
Target	 	 Funding %
to Revenue
 Target
	 	Plan
Funding
	 Threshold
	 	-5.84 mm	 	50%	 	31.875%  	 		 	Threshold	 	-53.00 mm	 	50%	 	10.625%
	 	 	 	 	 	 	 	 		 	Tier 1	 	-10.00 mm	 	95%	 	 
	 	 	Target	 	100%	 	63.75%	 		 	 	 	Target	 	100%	 	21.25%
	 	 	 	 	 	 	 	 		 	Tier 2	 	+10.00 mm	 	102%	 	 
	 Maximum
	 	+5.83 mm	 	150%	 	95.625%	 		 	Maximum	 	+159.00 mm	 	150%	 	31.875%
	 If actual Adjusted Operating Income results fall
 between the performance levels shown above, the

portion of bonus funding will be prorated accordingly.
	 	 	 	 If actual
Revenue results fall between the Tiers shown
 above, the portion of bonus funding will be prorated
accordingly.

  

 BONUS POOL FUNDING 
 At the end of the year, the President and Chief Executive Officer of Advanced Medical Optics, Inc. may recommend adjustments to the bonus funding levels to the
Organization, Compensation and Corporate Governance Committee (the “Committee”) after consideration of key operating results. When calculating Adjusted Operating Income and Revenue performance for purposes of this Plan, the Committee has
the discretion to include or exclude any or all of the following items: 
  

	•	 	 Extraordinary, unusual or non-recurring items 

  

	•	 	 Effects of accounting changes 

  

	•	 	 Effects of financing activities 

  

	•	 	 Expenses for restructuring or productivity initiatives 

  

	•	 	 Other non-operating items 

  

	•	 	 Spending for acquisitions 

  

	•	 	 Effects of divestitures 

  

 BONUS POOL DIFFERENTIATION BY BUSINESS UNIT/FUNCTION 
 The target bonus pool is determined by performance against Adjusted Operating Income (75%) and Revenue (25%). The factors below will be considered for allocation of SBU/function bonus pools: 
 CORPORATE STAFFS 
  

	•	 	 Corporate Adjusted Operating Income 

  

	•	 	 Corporate Revenue 

  

	•	 	 Strategic metrics and milestones 

 STRATEGIC
BUSINESS UNITS 
  

	•	 	 Business Unit Adjusted Operating Income 

  

	•	 	 Business Unit Revenue 

  

	•	 	 Strategic metrics 

 RESEARCH &
DEVELOPMENT, WORLD WIDE MANUFACTURING, GLOBAL CUSTOMER SERVICES, IT 
  

	•	 	 Strategic metrics and milestones 

 INDIVIDUAL BONUS AWARD CALCULATION 
 Target bonus awards are expressed as a percentage of the participant’s year-end annualized base salary. The target percentages for managers other than corporate
officers, as revised for 2007, vary by salary grade: 
  

			
	 SALARY GRADE
	 	 TARGET BONUS

	  5E *
	 	4.25%
	  6E *
	 	8.5%
	   7E    
	 	12.75%
	   8E    
	 	17%
	   9E    
	 	21.25%
	 10E    
	 	25.5%
	 11E    
	 	29.75%

 Target percentages or amounts for corporate officers are individually established by the Committee. The 2007
performance objectives do not apply to corporate officers who have been designated as 162(m) Participants. Performance targets for 162(m) Participants have not been amended. 
 A participant’s actual bonus award may vary above or below the targeted level based on the supervisor’s evaluation of his or her performance in relation to the predetermined MBOs. Each participant may
receive from 0% to 150% of his or her target bonus amount, which may be adjusted upwards or downwards based on the Company’s relative attainment of the pre-established financial performance objectives. 
 * U.S. and Puerto Rico employees only.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00127-of-00352.parquet"}]]